로딩 중…
지수 로딩 중…
KWANGDONG PHARMACEUTICAL CO.,LTD
009290· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩5,770-4.63%
2026-06-19
Price Chart
KWANGDONG PHARMACEUTICAL CO.,LTD-0.52%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 287.34B KRW |
| Revenue | 1.69T KRW |
| Net Income | 5.08B KRW |
| Total Assets | 1.32T KRW |
| Net Assets | 712.31B KRW |
| Employees | 1,072 |
| Value | |
| P/E | 56.58x |
| P/B | 0.40x |
| PEG | 1.84x |
| P/S | 0.17x |
| EV/EBITDA | 30.04x |
| FCF Yield | 19.89% |
| Profitability | |
| ROE | 0.71% |
| ROA | 0.39% |
| Op. Margin | 2.08% |
| Revenue Growth | 8.81% |
| Earnings Growth | 30.74% |
| Financial Health | |
| Debt Ratio | 185.09% |
| Total Debt | 306.19B KRW |
| FCF | 57.15B KRW |
| Cash | 96.62B KRW |
| Current Ratio | 1.30x |
| Net Debt/EBITDA | 12.67x |
| Dividend | |
| Div. Yield | 1.65% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -0.52% |
| 1M Return | -18.50% |
| From 52W High | -54.92% |
| 1Y MDD | -47.92% |
| Trading | |
| Volume | 387,472 shares |
| Foreign Own. | 17.20% |
| Per Share | |
| EPS | 417 KRW |
| BPS | 13,020 KRW |
Company Info
Kwangdong Pharmaceutical, established in 1963 and headquartered in Gwacheon-si, Gyeonggi-do, secured domestic consignment sales rights for Samdasoo until 2029 through a re-contract with Jeju Development Corporation in 2025. The company operates a Pharmacy Business Division for traditional medicines like Ssanghwatang and Woohwangchungsimwon, and an ETC Business Division for specialized pharmaceuticals such as the anti-cancer drug Lenara and vascular fortifier Venitol. Its F&B Sales Division markets beverages like Vita500, Corn Silk Tea, Hogaengnamu Tea, and Jeju Samdasoo, solidifying its brand power in the pharmaceutical and food sectors.